OSIRIS THERAPEUTICS, INC.

Delisted

CIK 1360886fmd_1HCE9BJF8MKFJ60KBVQF3Q69YJManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2009 to Dec 31, 2018, 36 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.